TITAN PHARMACEUTICALS INC Quarterly Costs and Expenses in USD from Q2 2018 to Q3 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Titan Pharmaceuticals Inc quarterly/annual Costs and Expenses history and growth rate from Q2 2018 to Q3 2023.
  • Titan Pharmaceuticals Inc Costs and Expenses for the quarter ending September 30, 2023 was $2.47M, a 9.75% decline year-over-year.
  • Titan Pharmaceuticals Inc annual Costs and Expenses for 2021 was $10.9M, a 10.7% decline from 2020.
  • Titan Pharmaceuticals Inc annual Costs and Expenses for 2020 was $12.2M, a 16.3% increase from 2019.
  • Titan Pharmaceuticals Inc annual Costs and Expenses for 2019 was $10.5M, a 29.6% decline from 2018.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 $2.47M -$267K -9.75% Jul 1, 2023 Sep 30, 2023 10-K 2024-04-01
Q2 2023 $1.67M -$921K -35.5% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $1.8M -$936K -34.3% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q3 2022 $10.7M $2.74M +$566K +26.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 $10.1M $2.59M -$178K -6.43% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 $10.3M $2.73M -$583K -17.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $10.9M $2.62M -$1.38M -34.5% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-25
Q3 2021 $12.3M $2.17M -$42K -1.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 $12.3M $2.77M -$97K -3.38% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $12.4M $3.31M +$213K +6.87% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 $12.2M $4.01M +$8.97M Oct 1, 2020 Dec 31, 2020 10-K 2022-03-25
Q3 2020 $3.22M $2.21M -$2.62M -54.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 $5.84M $2.87M -$2.52M -46.8% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 $8.35M $3.1M -$2.13M -40.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q4 2019 $10.5M -$4.96M Oct 1, 2019 Dec 31, 2019 10-K 2021-03-31
Q3 2019 $4.83M +$1.23M +34.1% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-16
Q2 2019 $5.38M +$2.08M +62.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
Q1 2019 $5.23M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-15
Q3 2018 $3.6M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $3.31M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.